Launch week offerEnds in00h00m00s

annual Promonthly Pro

David Broome

University of Michigan

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (17)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (11)

Casey Thornton

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Siri Atma W Greeley

Associate Professor of Pediatrics and Medicine

University of Chicago

UNITED STATES

View details

Allan Siperstein

Professor and Chair

Cleveland Clinic

UNITED STATES

View details

Wendy R. Uhlmann

University of Michigan

UNITED STATES

View details

Maria Cristina Foss-Freitas

University of Michigan

UNITED STATES

View details

Shane C. Quinonez

UNITED STATES

View details

Kristen Lee

Clinical Assistant Professor

University of Michigan

UNITED STATES

View details

Erin C. Cobry

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Scott Soleimanpour

University of Michigan

UNITED STATES

View details

Xin Jing

UNITED STATES

View details

Simeon Taylor

Professor of Medicine

University of Maryland School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Broome

Research Interests

Make your next move.

Explore related searches

Articles (17)

Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT)

606-P: Addressing Diabetes Distress in Clinical Practice—Provider Feedback and Resource Gaps following Screening Implementation

Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program

Discovery of CERS2 Haploinsufficiency Causing Atypical Lipodystrophy and Severe Fatty Liver Disease-Utility of Multiomics Analyses in the RADIANT study

GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659

American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors (vol 101, pg 285, 2025)

Novel Insulin Gene Variants in Antibody-Negative Adult-Onset Diabetes

Performance of Afirma Genomic Sequencing Classifier in Binary Subcategories of Atypia of Undetermined Significance Thyroid Nodules: Single Versus Repeat Diagnosis

Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY

Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine‐needle aspiration

SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI and Stroke

Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia

Use of Preoperative Imaging in Primary Hyperparathyroidism

Approach to the Patient with MODY-Monogenic Diabetes

Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY

Collaborators (11)

Casey Thornton

Siri Atma W Greeley

Allan Siperstein

Wendy R. Uhlmann

Maria Cristina Foss-Freitas

Shane C. Quinonez

Kristen Lee

Erin C. Cobry

Scott Soleimanpour

Xin Jing

Simeon Taylor

Make your next move.